Molecular imaging in cardiovascular disease: Which methods, which diseases?

Jonathan Lindner, Albert Sinusas

    Research output: Contribution to journalArticle

    14 Citations (Scopus)

    Abstract

    Techniques for in vivo assessment of disease-related molecular changes are being developed for all forms of non-invasive cardiovascular imaging. The ability to evaluate tissue molecular or cellular phenotype in patients has the potential to not only improve diagnostic capabilities but to enhance clinical care either by detecting disease at an earlier stage when it is more amenable to therapy, or by guiding most appropriate therapies. These new techniques also can be used in research programs in order to characterize pathophysiology and as a surrogate endpoint for therapeutic efficacy. The most common approach for molecular imaging involves the creation of novel-targeted contrast agents that are designed so that their kinetic properties are different in disease tissues. The main focus of this review is not to describe all the different molecular imaging approaches that have been developed, but rather to describe the status of the field and highlight some of the clinical and research applications that molecular imaging will likely provide meaningful benefit. Specific target areas include assessment of atherosclerotic disease, tissue ischemia, and ventricular and vascular remodeling.

    Original languageEnglish (US)
    Pages (from-to)990-1001
    Number of pages12
    JournalJournal of Nuclear Cardiology
    Volume20
    Issue number6
    DOIs
    StatePublished - Dec 2013

    Fingerprint

    Molecular Imaging
    Cardiovascular Diseases
    Ventricular Remodeling
    Research
    Contrast Media
    Therapeutics
    Ischemia
    Biomarkers
    Phenotype

    Keywords

    • angiogenesis
    • atherosclerosis
    • Molecular imaging
    • remodeling

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine
    • Radiology Nuclear Medicine and imaging

    Cite this

    Molecular imaging in cardiovascular disease : Which methods, which diseases? / Lindner, Jonathan; Sinusas, Albert.

    In: Journal of Nuclear Cardiology, Vol. 20, No. 6, 12.2013, p. 990-1001.

    Research output: Contribution to journalArticle

    @article{f2eb62231e4642e0b2b735ef94415502,
    title = "Molecular imaging in cardiovascular disease: Which methods, which diseases?",
    abstract = "Techniques for in vivo assessment of disease-related molecular changes are being developed for all forms of non-invasive cardiovascular imaging. The ability to evaluate tissue molecular or cellular phenotype in patients has the potential to not only improve diagnostic capabilities but to enhance clinical care either by detecting disease at an earlier stage when it is more amenable to therapy, or by guiding most appropriate therapies. These new techniques also can be used in research programs in order to characterize pathophysiology and as a surrogate endpoint for therapeutic efficacy. The most common approach for molecular imaging involves the creation of novel-targeted contrast agents that are designed so that their kinetic properties are different in disease tissues. The main focus of this review is not to describe all the different molecular imaging approaches that have been developed, but rather to describe the status of the field and highlight some of the clinical and research applications that molecular imaging will likely provide meaningful benefit. Specific target areas include assessment of atherosclerotic disease, tissue ischemia, and ventricular and vascular remodeling.",
    keywords = "angiogenesis, atherosclerosis, Molecular imaging, remodeling",
    author = "Jonathan Lindner and Albert Sinusas",
    year = "2013",
    month = "12",
    doi = "10.1007/s12350-013-9785-0",
    language = "English (US)",
    volume = "20",
    pages = "990--1001",
    journal = "Journal of Nuclear Cardiology",
    issn = "1071-3581",
    publisher = "Springer New York",
    number = "6",

    }

    TY - JOUR

    T1 - Molecular imaging in cardiovascular disease

    T2 - Which methods, which diseases?

    AU - Lindner, Jonathan

    AU - Sinusas, Albert

    PY - 2013/12

    Y1 - 2013/12

    N2 - Techniques for in vivo assessment of disease-related molecular changes are being developed for all forms of non-invasive cardiovascular imaging. The ability to evaluate tissue molecular or cellular phenotype in patients has the potential to not only improve diagnostic capabilities but to enhance clinical care either by detecting disease at an earlier stage when it is more amenable to therapy, or by guiding most appropriate therapies. These new techniques also can be used in research programs in order to characterize pathophysiology and as a surrogate endpoint for therapeutic efficacy. The most common approach for molecular imaging involves the creation of novel-targeted contrast agents that are designed so that their kinetic properties are different in disease tissues. The main focus of this review is not to describe all the different molecular imaging approaches that have been developed, but rather to describe the status of the field and highlight some of the clinical and research applications that molecular imaging will likely provide meaningful benefit. Specific target areas include assessment of atherosclerotic disease, tissue ischemia, and ventricular and vascular remodeling.

    AB - Techniques for in vivo assessment of disease-related molecular changes are being developed for all forms of non-invasive cardiovascular imaging. The ability to evaluate tissue molecular or cellular phenotype in patients has the potential to not only improve diagnostic capabilities but to enhance clinical care either by detecting disease at an earlier stage when it is more amenable to therapy, or by guiding most appropriate therapies. These new techniques also can be used in research programs in order to characterize pathophysiology and as a surrogate endpoint for therapeutic efficacy. The most common approach for molecular imaging involves the creation of novel-targeted contrast agents that are designed so that their kinetic properties are different in disease tissues. The main focus of this review is not to describe all the different molecular imaging approaches that have been developed, but rather to describe the status of the field and highlight some of the clinical and research applications that molecular imaging will likely provide meaningful benefit. Specific target areas include assessment of atherosclerotic disease, tissue ischemia, and ventricular and vascular remodeling.

    KW - angiogenesis

    KW - atherosclerosis

    KW - Molecular imaging

    KW - remodeling

    UR - http://www.scopus.com/inward/record.url?scp=84890923426&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84890923426&partnerID=8YFLogxK

    U2 - 10.1007/s12350-013-9785-0

    DO - 10.1007/s12350-013-9785-0

    M3 - Article

    C2 - 24092271

    AN - SCOPUS:84890923426

    VL - 20

    SP - 990

    EP - 1001

    JO - Journal of Nuclear Cardiology

    JF - Journal of Nuclear Cardiology

    SN - 1071-3581

    IS - 6

    ER -